Filed: 8/14/2023ACC: 0000905148-23-000738
📋 What this filing means
VENBIO PARTNERS LLC filed this quarterly 13F‑HR report disclosing 7 equity positions with a total reported market value of $276.31M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
7
Positions
$276.31M
Total AUM (reported)
24.96M
Total Shares
Allocation by class
COM$276.31M100.0%
Portfolio Concentration
Top 3$218.03M78.9%
4–10$58.28M21.1%
Top 3 weight
78.9%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 24.96M
Sole
Full voting authority
24.96M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole7
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings7
Rows:
ACELYRIN INC
SOLEShares3.86M
TypeSH
Market value$80.62M
29.18%
Sole
3.86M
Shared
0.00
None
0.00
ALX ONCOLOGY HLDGS INC
SOLEShares9.70M
TypeSH
Market value$72.85M
26.36%
Sole
9.70M
Shared
0.00
None
0.00
PHARVARIS N V
SOLEShares4.26M
TypeSH
Market value$64.57M
23.37%
Sole
4.26M
Shared
0.00
None
0.00
HARMONY BIOSCIENCES HLDGS IN
SOLEShares1.04M
TypeSH
Market value$36.44M
13.19%
Sole
1.04M
Shared
0.00
None
0.00
VENTYX BIOSCIENCES INC
SOLEShares424.03K
TypeSH
Market value$13.91M
5.03%
Sole
424.03K
Shared
0.00
None
0.00
ELEVATION ONCOLOGY INC
SOLEShares2.91M
TypeSH
Market value$4.43M
1.60%
Sole
2.91M
Shared
0.00
None
0.00
IMPEL PHARMACEUTICALS INC
SOLEShares2.76M
TypeSH
Market value$3.50M
1.27%
Sole
2.76M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ACELYRIN INCSOLE | COM | 3.86M | SH | $80.62M 29.18% | 3.86M | 0.00 | 0.00 |
ALX ONCOLOGY HLDGS INCSOLE | COM | 9.70M | SH | $72.85M 26.36% | 9.70M | 0.00 | 0.00 |
PHARVARIS N VSOLE | COM | 4.26M | SH | $64.57M 23.37% | 4.26M | 0.00 | 0.00 |
HARMONY BIOSCIENCES HLDGS INSOLE | COM | 1.04M | SH | $36.44M 13.19% | 1.04M | 0.00 | 0.00 |
VENTYX BIOSCIENCES INCSOLE | COM | 424.03K | SH | $13.91M 5.03% | 424.03K | 0.00 | 0.00 |
ELEVATION ONCOLOGY INCSOLE | COM | 2.91M | SH | $4.43M 1.60% | 2.91M | 0.00 | 0.00 |
IMPEL PHARMACEUTICALS INCSOLE | COM | 2.76M | SH | $3.50M 1.27% | 2.76M | 0.00 | 0.00 |